Hyderabad, May 16: The price of COVID-19 vaccine Corbevax has been reduced to Rs 250 a dose from its earlier Rs 840, said Biological E Limited (BE) on Monday. For end-user, the price would be Rs 400 a dose, including taxes and administration charges, added the pharmaceutical company.

Earlier in April, the Drugs Controller General of India (DCGI) granted emergency use authorisation to Biological E's COVID-19 vaccine Corbevax for those aged 5 to 12 years, informed the pharmaceutical company. Corbevax is currently being administered to children in the age group of 12-14. Biological E's COVID-19 Vaccine Corbevax Gets Emergency Approval For 12-18 Age Group From DCGI.

Biological E Limited has manufactured 30 crore doses of Corbevax and has already supplied nearly 10 crore doses to the Central Government. Currently, over 3 crore doses of Corbevax have been administered to children between 12-15 years of age.

COVID-19 vaccination for minors in India started from January 3 onwards for those in the 15-18 age group with Bharat Biotech's Covaxin. The drive later expanded on March 16 to include children aged above 12 for Corbevax. India is currently administering two COVID-19 vaccines for children above 12.

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)